
Three Aussie Stocks to Watch
Reports that a unit of Evergrande has negotiated a coupon payment with bondholders and a significant injection of liquidity from the Peoples Bank of China this morning has further eased fears over Chinese property developer Evergrande, prompting a recovery in the ASX200.
Share this:
Below are three Aussie stocks worth watching:
1. Orocobre (ORE)
Orocobre is a lithium producer whose share price has benefited in recent months from a lift in lithium’s price to multi-year highs due to the global move towards decarbonisation and tight supply. Yesterday the share price of Orocobre traded to a low of $8.19, almost 20% below its $10.08 high of last week as speculative money exited the space courtesy of the Evergrande scare and following a broker downgrade. Technically this week’s pullback is viewed as part of a corrective pullback. Providing technical support $8.20/10 area holds the expectation is for a retest and break of recent highs $10.00 area.
2. IDT (IDT)
IDT is a pharmaceutical company based in Melbourne and a solid contender to manufacture a COVID-19 mRNA vaccine for the Australian government. The share price of IDT initially rallied from .17c in March of this year when IDT issued a release, noting it was assessing the viability of producing a vaccine. In late August, it announced it was in a “state of readiness to produce a COVID-19 vaccine” that propelled the shares up to .755c. IDT is one of the only pharmaceutical companies in Australia with a sterile facility ready to produce a vaccine and probably the only one with spare capacity. For this reason and given the need for vaccines to be produced locally in the years to come, IDT is a company worth a second look.
3. QANTAS (QAN)
Australia’s national airline is currently enjoying the prospect of reopening as domestic vaccination rates continue to climb. Tourism Minister Dan Tehan said today that Australians will be able to travel aboard unrestricted by no later than Christmas once the vaccination rate in their respective states hits 80%. The Qantas stock price has rallied over 30% in the past three weeks from $4.20 to a high of $5.56, in anticipation of a travel boom from pent-up demand from a nation of people who love to travel. Dips should be well supported near $5.00 looking for a test of the November 2020, $5.79 high, before the next upside target at $6.20.
Source Tradingview. The figures stated areas of September 22nd, 2021. Past performance is not a reliable indicator of future performance. This report does not contain and is not to be taken as containing any financial product advice or financial product recommendation
Latest market news
View more newsOpen an account in minutes
Experience award-winning platforms with fast and secure execution, and enjoy tight spreads from 0.5 pts on FX and 0.3 pts on indices.
Economic calendar
Web Trader platform
Our sophisticated web-based platform is packed with features.

ASX 200 Rebound Stalls Despite Wall Street Surge
The ASX 200 rebound is struggling for traction despite a powerful Wall Street rally, leaving 8800 resistance and downside risks in focus.

ASX 200 Rebounds, But Resistance Looms
The ASX 200 has rebounded from the July low, but resistance around 8800 and 8875 could test the recovery.

ASX 200 Slides as Oil, Yields and Rate Risks Hit Sentiment
The ASX 200 suffered its worst week in six months as surging oil, higher bond yields and renewed rate-hike bets drove a broad risk-off move.
This report is intended for general circulation only. It should not be construed as a recommendation, or an offer (or solicitation of an offer) to buy or sell any financial products. The information provided does not take into account your specific investment objectives, financial situation or particular needs. Before you act on any recommendation that may be contained in this report, independent advice ought to be sought from a financial adviser regarding the suitability of the investment product, taking into account your specific investment objectives, financial situation or particular needs.
StoneX Financial Pte. Ltd., may distribute reports produced by its respective foreign entities or affiliates within the StoneX group of companies or third parties pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the report is distributed to a person in Singapore who is not an accredited investor, expert investor or an institutional investor (as defined in the Securities Futures Act), StoneX Financial Pte. Ltd. accepts legal responsibility to such persons for the contents of the report only to the extent required by law. Singapore recipients should contact StoneX Financial Pte. Ltd. at 6826 9988 for matters arising from, or in connection with the report.
In the case of all other recipients of this report, to the extent permitted by applicable laws and regulations neither StoneX Financial Pte. Ltd. nor its associated companies will be responsible or liable for any loss or damage incurred arising out of, or in connection with, any use of the information contained in this report and all such liability is hereby expressly disclaimed. No representation or warranty is made, express or implied, that the content of this report is complete or accurate.
StoneX Financial Pte. Ltd. is not under any obligation to update this report.
Trading CFDs carries a high level of risk that may not be suitable for some investors. Consider your investment objectives, level of experience, financial resources, risk appetite and other relevant circumstances carefully. The possibility exists that you could lose some or all of your investments, including your initial deposits. If in doubt, please seek independent expert advice. Visit www.forex.com/en-sg/terms-and-policies for the complete Risk Disclosure Statement.






